Hill-Rom (NYSE:HRC) said today that it agreed to put up $300 million for Mortara Instrument and its line of diagnostic cardiology and patient monitoring devices, not including a $40 million “tax benefit” the company expects to gain by structuring the buyout a certain way. Milwaukee-based Mortara makes an eponymous line of cardiac monitoring devices, plus the Quinton […]
Hillrom
Hill-Rom enters home monitoring arena with Welch Allyn hypertension program
Hill-Rom (NYSE:HRC) said today it is entering the home monitoring field as its subsidiary Welch Allyn launches its Home Hypertension program. The program will allow patients to monitor their health at home using Welch Allyn’s home blood pressure monitor, which can sync to a smartphone app to pursue healthy blood pressure goals. The smartphone app is […]
Hill-Rom picks up Tridien Medical, inks $1.5B term loan, reportedly deals WatchChild
Update: Added more information and comments from PeriGen. Hill-Rom (NYSE:HRC) said it paid an undisclosed amount for patient positioning device maker Tridien Medical and took out a $1.45 billion loan, and reportedly dealt its WatchChild fetal monitoring business to PeriGen. Chicago-based Hill-Rom said it picked up Anodyne Medical Device, which operates under the name Tridien Medical, […]
Hill-Rom posts Q3 earnings beat, raises outlook
Hill-Rom Holdings (NYSE:HRC) shares are up slightly today after the company reported higher-than-expected earnings for the 3rd quarter, lifting its outlook for the 4th and full fiscal year. The Chicago-based company reported profits of $45 million, or 68¢ per share, on sales of $556 million for the 3 months ended June 30. That amounts to […]
Hill-Rom launches VisiVest connected airway clearance system
Hill-Rom Holdings (NYSE:HRC) said today it launched the VisiVest System designed for patients in need of airway clearance therapy. The newly launched system combines high-frequency chest-wall oscillation technology, as well as wireless connectivity, enabled by Qualcomm‘s (NASDAQ: QCOM) Qualcomm Life subsidiary, to allow therapy adherence data to be transmitted to caregivers to improve clinical decision making, the […]
Hill-Rom slides on Q2 revenues miss
Hill-Rom (NYSE:HRC) shares took a hit today after the company reported that fiscal 2nd-quarter sales missed expectations despite the contribution of new acquisition Welch Allyn. Chicago-based Hill-Rom said profits were $22.3 million, or 33¢ per share, on sales of $632.6 million for the 3 months ended March 31, for a -14.6% bottom-line slide on sales growth […]
Intuitive Surgical: Q4, FY2015 earnings trounce street; New FDA 510(k)
Intuitive Surgical (NSDQ:ISRG) released a bevy of good news today, posting Q4 and fiscal year 2014 earnings that trounced street estimates and announcing FDA 510(k) clearance for the Integrated Table Motion for the da Vinci Xi surgical system. Intuitive Surgical reported profits of $190 million, or $4.99 per share, on sales of $676.5 million for the 3 months […]
Fed. Circ. upholds Hill-Rom patent’s invalidity
The United States Court of Appeals for the Federal Circuit today upheld a previous ruling by the Patent Trial and Appeal Board which found Hill-Rom Holdings (NYSE:HRC) patent for hospital bed monitoring systems invalid. The Court of Appeals affirmed the Board’s previous decision, which found the patent owned by Hill-Rom to be invalid for reasons […]
Hill-Rom jumps on Q4 beat, raised guidance
Hill-Rom Holdings (NYSE:HRC) shares jumped after releasing 4th quarter earnings last week that beat the street on revenue and earnings per share, along with solid fiscal year 2015 numbers and fiscal 2016 guidance. Hill-Rom reported losses of $10.1 million, or 16¢ per share, on sales of $573.9 million for the 3 months ended Sept 30. […]
OmniGuide vet Avila gets picked as new IlluminOss CEO | Personnel Moves
IlluminOss Medical said today it picked ex-OmniGuide sales & marketing veep Manny Avila as its new chief exec. Prior to his time as sales & marketing veep with OmniGuide, Avila served as veep of commercial operations and surgical solutions in Europe for Covidien, and had management roles at Aspect Medical, Synthes Inc. and Haemonetics (NYSE:HAE), IlluminOss […]
Hill-Rom raises outlook after $2B Welch Allyn buy
Hill-Rom Holdings (NYSE:HRC) today raised its earnings outlook for its fiscal 4th quarter and full year 2015, a little more than 2 weeks after closing its $2.05 billion acquisition of Welch Allyn. Chicago-based Hill-Rom said it now expects adjusted 4th-quarter EPS of 80¢ to 82¢, up from prior guidance of 76¢ to 79¢. Full-year adjusted EPS are now pegged at $2.55 […]